Healthcare Sector Comment – January 2017

As a new year rolls in and people adopt resolutions to be healthier and exercise more, vitamins, minerals and supplements (VMS) are flying off the shelves. Driven by increased take-up of sport and growing demand for natural ingredients, the

Find out more...

Healthcare Sector Comment – December 2016

Transaction activity is booming in the elderly residential care market. This is being driven on by the availability of cheap debt, an increasingly ageing population, rising demand for specialist care for conditions such as dementia, and reablement care. In

Find out more...

Healthcare Sector Comment – November 2016

On 9th November 2016, Donald Trump became the 45th US President-Elect, so what does this mean for the healthcare M&A market? First, during campaigning Trump promised to cut down on tax inversion M&A, which avoids US corporate taxes on

Find out more...

Healthcare Sector Comment – October 2016

Biotech/Biopharma companies are seeing a resurgence of M&A activity as we near the end of the year, despite the negative media attention around drug pricing, political pressure and tighter healthcare budgets – driven by the following: several biotech drugs

Find out more...